HIV reproducibly establishes a latent infection after acute infection of T cells in vitro

No abstract is available for this paper.

• Publication year

  2003

• Venue

  EMBO Journal

• Publication date

  2003-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/emboj/cdg188PMID 12682019PMCID PMC154479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• A quantitative assay for HIV DNA integration in vivo

  2001cited by this paper
• The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

  2001cited by this paper
• Detection and Direct Genomic Sequencing of Multiple Rare Unknown Flanking DNA in Highly Complex Samples

  2001cited by this paper
• Translating the Histone Code

  2001cited by this paper
• Re-SET-ting heterochromatin by histone methyltransferases.

  2001cited by this paper
• Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities.

  2000cited by this paper
• Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

  2000cited by this paper
• Multiple Blocks to Human Immunodeficiency Virus Type 1 Replication in Rodent Cells

  2000cited by this paper
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

  1999cited by this paper
• Latent reservoirs of HIV: obstacles to the eradication of virus.

  1999cited by this paper
• Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

  1999cited by this paper
• Tackling Tat.

  1999cited by this paper
• Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines

  1998cited by this paper
• Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target

  1998cited by this paper
• Mutations in the tat Gene Are Responsible for Human Immunodeficiency Virus Type 1 Postintegration Latency in the U1 Cell Line

  1998cited by this paper
• Unfolding the mysteries of heterochromatin.

  1998cited by this paper
• Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

  1997cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

  1997cited by this paper
• Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation.

  1996cited by this paper
• A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.

  1996cited by this paper
• A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome.

  1995cited by this paper
• HIV Integration: Ini1 for integration?

  1995cited by this paper
• Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.

  1994cited by this paper
• Position effect variegation in yeast.

  1994cited by this paper
• NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.

  1994cited by this paper
• NF-κ B-Dependent and -Independent Pathways of HIV Activation in a Chronically Infected T Cell Line

  1994cited by this paper
• Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

  1993cited by this paper
• Cytokine modulation of HIV expression.

  1993cited by this paper
• A SURVEY OF THE GENOMIC DISTRIBUTION OF ALPHA SATELLITE DNA ON ALL THE HUMAN CHROMOSOMES, AND DERIVATION OF A NEW CONSENSUS SEQUENCE

  1991cited by this paper
• A survey of the genomic distribution of alpha satellite DNA on all the human chromosomes, and derivation of a new consensus sequence.

  1991cited by this paper
• Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation

  1981cited by this paper

• Bipolar CD4-targeted dual-DARPin-55/57 lipid nanoparticle enables efficient CRISPR/Cas-mediated HIV-1 DNA excision and reactivation blockade in latent CD4 T cell lines.

  2026cites this paper
• Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation

  2026influential citation
• Q4ddPCR: a flexible, 4-target assay for high-resolution HIV reservoir profiling.

  2026cites this paper
• Fragment‐Based Design of Pseudo‐Natural Products, Synthesis, and Evaluation of Their HIV‐1 Latency‐Reversing Properties

  2026influential citation
• The Differentially Regulated Cousins: Insights into the Differences in Transcriptional Regulatory Mechanisms Between HTLV-1 and HIV-1

  2026cites this paper
• Selective reactivation of latent HIV using CyclinT1-Tat-containing virus-like particles.

  2026cites this paper
• Traditional Medicine Extracts of Gnidia sericocephala and Product Nkabinde in HIV-1 Latency Reversal: Insights from J-Lat Subtype B and J-Lat Subtype C Models

  2026cites this paper
• The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir

  2026cites this paper
• Harziachalasins A–G, polycyclic-fused cytochalasins from the endophytic fungus Trichoderma harzianum MLJ-4 with HIV latency reversal activity

  2026influential citation
• Transcription of HIV-1 is heterogenous among authentic latent CD4+ T cell clones.

  2026cites this paper
• Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in “Kick-and-Kill” HIV Cure Approaches

  2026influential citation
• Lithium attenuates HIV-1 latency reversal in an autophagy-independent way

  2025cites this paper
• The Complex Interactions Between HIV-1 and Human Host Cell Genome: From Molecular Mechanisms to Clinical Practice

  2025cites this paper
• Extracellular condensates (ECs) are endogenous modulators of HIV transcription and latency reactivation.

  2025cites this paper
• Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency

  2025cites this paper
• Argonaute 1 contributes to the transcriptional silencing of HIV-1

  2025cites this paper
• Application of HIV-1 viral protein R-derived-peptides as new E3 ligase-binding components of BRD4 degraders

  2025cites this paper
• Activating PKC-ε induces HIV expression with improved tolerability

  2025cites this paper
• Q4ddPCR (May the Fourth Be Precise): A Flexible, 4-Target Assay for High-Resolution HIV Reservoir Profiling

  2025cites this paper
• Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal

  2025cites this paper
• Considerations and limitations for establishing an Intact Proviral DNA Assay (IPDA) on a chip-based digital PCR system for HIV-1 reservoir quantification.

  2025cites this paper
• Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency

  2025influential citation
• From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir

  2025cites this paper
• Ex vivo HIV DNA integration in STAT3 drives T cell persistence—A model of HIV-associated T cell lymphoma

  2025cites this paper
• Chemoproteomics Reveals FAM114A2 as a Functional Target of Wikstroelide E for Reversal of HIV-1 Latency.

  2025cites this paper
• SARS-CoV-2 S protein activates the HIV latent reservoir through the mTOR pathway

  2025cites this paper
• Replication-driven HBV cccDNA loss in chimeric mice with humanized livers

  2025cites this paper
• Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line models

  2025cites this paper
• Reactivation of latent HIV-1 by the glucocorticoid receptor modulator AZD9567

  2025influential citation
• Integrative Assessment of Total and Intact HIV-1 Reservoir by a 5-Region Multiplexed Rainbow DNA Digital PCR Assay.

  2025cites this paper
• Mathematical modeling and mechanisms of HIV latency for personalized anti latency therapies

  2025cites this paper
• Deciphering lentiviral Vpr/Vpx determinants required for HUSH and SAMHD1 antagonism highlights the molecular plasticity of these evolutionary conflicts

  2025cites this paper
• A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency

  2025cites this paper
• RYBP promotes HIV-1 latency through promoting H2AK119ub and decreasing H3K4me3

  2025cites this paper
• Ethnopharmacological exploration and isolation of HIV-1 latency-reversing agents from Sudanese medicinal plants

  2025influential citation
• Rigorous Process for Isolation of Gut-Derived Extracellular Vesicles (EVs) and the Effect on Latent HIV

  2025cites this paper
• HIV Tat as a latency reversing agent: turning the tables on viral persistence

  2025cites this paper
• The role of Tat in HIV latency and reactivation

  2025cites this paper
• Single cell analysis of HIV expression and integration sites reveals robust viral expression across diverse chromatin environments

  2025cites this paper
• In vitro HIV DNA integration in STAT3 drives T cell persistence—A model of HIV-associated T cell lymphoma

  2025cites this paper
• Effects of Oxygen Atom Position in Linear Side Chains of Ansellone Analogues on HIV Latency-Reversing Activity.

  2025cites this paper
• Using single cell technologies to understand HIV latency models.

  2025cites this paper
• HIV-1 latency: From acquaintance to confidant

  2025cites this paper
• A high-throughput, microplate reader-based method to monitor in vitro HIV latency reversal in the absence of flow cytometry.

  2025cites this paper
• BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription

  2025cites this paper
• Fast pH‐Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes

  2025cites this paper
• Liquid–liquid phase separation of LARP7 restrains HIV-1 replication

  2025cites this paper
• A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients

  2025influential citation
• Retinol Binding Protein 4 reactivates latent HIV-1 via the JAK/STAT5 and JNK pathways

  2025cites this paper
• The p400 complex promotes HIV-1 latency by suppressing viral transcription and altering the host cell state

  2025influential citation
• NF-κB-Driven HIV-1 Gene Expression in Human Cells Is Independent of Poly(ADP-ribose) polymerase-1 Function

  2025cites this paper
• Efficient mRNA delivery to resting T cells to reverse HIV latency

  2025cites this paper
• HIV proviral transcription and infectivity are enhanced by neddylation

  2025influential citation
• Retinol Binding Protein 4 reactivates latent HIV-1 by triggering canonical NF-κB, JAK/STAT5 and JNK signalling

  2025cites this paper
• The influence of HIV sense and antisense transcripts on stochastic HIV transcription and reactivation

  2025cites this paper
• Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV

  2025cites this paper
• CHIP/STUB1 suppresses the transcription and latent reactivation of HIV-1 via the TRAF6-NF-κB-HIV-LTR axis

  2025cites this paper
• HIV-1 latency reversing agents converge on phosphoregulation of nuclear protein complexes

  2025influential citation
• Glucose-Fueled Histone Modifications Drive HIV-1 Latency Reversal at Hypoxia

  2025cites this paper
• HIV-1 transcription dominates over host gene activity at the HIV-1 integration site

  2025cites this paper
• Heat shock protein 90 is a chaperone regulator of HIV-1 latency

  2025cites this paper
• The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner

  2025influential citation
• Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation

  2024influential citation
• Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice

  2024cites this paper
• Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence

  2024influential citation
• Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy.

  2024cites this paper
• Croton oligandrus Pierre & Hutch (Euphorbiaceae) Extracts and Isolated Compounds Reverse HIV-1 Latency

  2024cites this paper
• Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa

  2024cites this paper
• NSC95397 Is a Novel HIV-1 Latency-Reversing Agent

  2024cites this paper
• Antibody-Free Glycogen Nanoparticles Engage Human Immune T Cells for Intracellular Delivery of Small Drugs or mRNA.

  2024cites this paper
• Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal

  2024cites this paper
• Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal

  2024cites this paper
• Ex vivo and in vivo HIV-1 latency reversal by “Mukungulu,” a protein kinase C-activating African medicinal plant extract

  2024influential citation
• Discovery of new acetamide derivatives of 5-indole-1,3,4-oxadiazol-2-thiol as inhibitors of HIV-1 Tat-mediated viral transcription

  2024influential citation
• SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects

  2024cites this paper
• Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal

  2024cites this paper
• HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy

  2024cites this paper
• Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells

  2024cites this paper
• Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets

  2024influential citation
• Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression

  2024cites this paper
• Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR

  2024influential citation
• Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells

  2024influential citation
• RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR

  2024cites this paper
• Total Syntheses of Phorbol and 11 Tigliane Diterpenoids and Their Evaluation as HIV Latency-Reversing Agents.

  2024cites this paper
• Transcription of HIV-1 at sites of intact latent provirus integration

  2024cites this paper
• Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.

  2024cites this paper
• PADI4-mediated citrullination of histone H3 stimulates HIV-1 transcription

  2024cites this paper
• Transcriptional priming and chromatin regulation during stochastic cell fate specification

  2024cites this paper
• CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells

  2024cites this paper
• Transcription of HIV-1 at sites of intact latent provirus integration

  2024cites this paper
• Cognate Antigen Engagement Induces HIV-1 Expression In CD4+ T Cells From People On Long-Term ART

  2024cites this paper
• A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis

  2024cites this paper
• Specific quantification of inducible HIV-1 reservoir by RT-LAMP

  2024influential citation
• Putting a Kink in HIV-1 Particle Infectivity: Rocaglamide Inhibits HIV-1 Replication by Altering Gag-Genomic RNA Interaction

  2024influential citation
• A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?

  2024influential citation
• Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation

  2024cites this paper
• HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies

  2024influential citation
• CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells

  2024cites this paper
• CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation

  2024influential citation
• Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk

  2024cites this paper